Back to results
US 9,867,825 B2Granted
Pharmaceutical combination comprising binimetinib
AssigneeNovartis AG
InventorsGiordano Caponigro, Scott Delach, Shivang Doshi, Thomas Horn-Spirohn, Sunkyu Kim
Life of this patent
Estimating the term…
Abstract
A combination of a CDK4/6 inhibitor and a MEK inhibitor for the treatment of diseases such as cancer.
Claims12
A combination comprising
- (a) a first agent Compound A of Formula A
- or a pharmaceutically acceptable salt thereof and
- (b) a second agent Compound B of Formula B
- or a pharmaceutically acceptable salt thereof.
1 more element
A method of treating cancer comprising administer to a subject in need of such treatment
- (a) a first agent Compound A of Formula A
- or a pharmaceutically acceptable salt thereof and
- (b) a second agent Compound B of Formula B
- or a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.